Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

BridgeHead's ‘VNA Redefined' Clinics will shed light on ‘Vendor Neutral Archiving' at the UK RC 2011

June 1, 2011 1:34 am | by RealWire | News | Comments

With NHS contracts for Picture and Archiving Communication Systems (PACS) expiring in 2013, healthcare IT leaders contemplating the future of their PACS environments can join BridgeHead Software to explore how VNAs can improve their Electronic Patient Record infrastructuresAshtead, UK -...

FDA Approves Marketing of RMS Subcutaneous Needle Sets

June 1, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

CHESTER, N.Y., June 1, 2011 /- Repro-Med Systems, Inc., (REPR.PK) announced today that it has received approval from the Food and Drug Administration (FDA) to begin U.S. marketing of its new Subcutaneous Needle Sets which the company is promoting as the HIgh Flo™ RMS Subcutaneous...

VisiInc PLC and MMRGlobal Announce Agreement to Launch MyMedicalRecords Australia

June 1, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES and PERTH, Australia, June 1, 2011 /- MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") and VisiInc PLC (VZJ) ( www.deutsch-boerse.com ) have entered into an agreement to launch MMRGlobal's patented consumer and professional health IT products and services, including MMRPro for healthcare...

Advertisement

The Brain Stimulation Headset from Valkee Makes Light Work of Jet Lag, Job Stress and Winter Blues

June 1, 2011 12:34 am | by RealWire | News | Comments

The Brain Stimulation Headset, Valkee (http://www.valkee.com), substitutes the mood-elevating effects of the sun, by channelling safe bright light directly to photosensitive regions of the brain through the ear canal. Valkee has been proven to increase energy, and can act as a...

P & G Welcomes New Members to U.S. Sustainability Expert Advisory Panel

May 31, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

CINCINNATI, May 31, 2011 /- The Procter & Gamble Company (NYSE: PG ) today announced that three new members have joined its U.S. Sustainability Expert Advisory Panel (SEAP). The new members are: Caroline Hermans, Ph.D. – Commitments Senior Manager, Clinton Global Initiative Dr....

MIM's Medical Imaging App for Patients, VueMe, Now Available on iPad, iPhone, and iPod touch

May 31, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, May 31, 2011 /- MIM Software Inc., a leading global provider of medical imaging software, is proud to announce that the VueMe App for iPad, iPhone, and iPod touch is now available on the App Store. This new app, designed specifically for patient use, allows patients to view...

IMD Companies, Inc. Announces OMI Operations in Florida

May 31, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

TAMPA, Fla., May 31, 2011 /- Following through with plans to expand its Medical Diagnostics operations, Optimum Mobile Imaging (OMI) has started services in Florida. Currently operating on a fee for service basis, OMI is submitting the paperwork necessary for insurance company contracting...

Final Published Trial Data in The Lancet Supports Safety and Effectiveness of MicroVention-Terumo's HydroCoil® Embolic System for Treatment of Cerebral Aneurysms

May 31, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

TUSTIN, Calif., May 31, 2011 /- MicroVention-Terumo, Inc., a leader in developing, manufacturing and marketing interventional neurovascular devices, announced today the final 18-month follow-up data in a landmark international study. The HydroCoil® Endovascular Aneurysm Occlusion and...

Advertisement

HeartSine® Increases AED System Warranty to Longest in the Industry

May 31, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

NEWTOWN, Pa., May 31, 2011 /- HeartSine Technologies, Inc, a world leader in personal and public access defibrillators, has increased its system warranty period to an exclusive 10 years on its popular HeartSine ® samaritan ® PAD 300P Public Access Defibrillator (PAD) for the...

Acurest's Custom CPAP Mask Now Available for Sleep Apnea Sufferers in the U.S.

May 31, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

DALLAS, May 31, 2011 /- Acurest, the world's only provider of custom-made Continuous Positive Airway Pressure (CPAP) nasal masks for the treatment of sleep apnea disorder, announced that the solution is now available to sleep apnea sufferers in the U.S. Made specifically for each...

Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer

May 31, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

MALVERN, Pa., May 31, 2011 /- Fujirebio Diagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance to the CYFRA 21-1™ EIA assay to monitor disease progression during the course of disease and treatment of lung cancer patients....

SpeechTrans Offers Mobile Translation App for Hearing Impaired

May 31, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

POINT PLEASANT BEACH, N.J., May 31, 2011 /- SpeechTrans, a leader in app-based multi-language translation, announced today the launch of SpeechTrans Ultimate for Hearing Impaired. The new app enables the hearing impaired to conduct real-time two-way conversations in English, Spanish,...

CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment

May 31, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

KING OF PRUSSIA, Pa., May 31, 2011 /- CSL Behring announced today that it has been granted Orphan Drug Designations (ODD) by the European Commission for the development of its recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP), a novel therapy to treat...

Advertisement

Brin Wojcicki Foundation Announces $50-Million Challenge Grant to Michael J. Fox Foundation to Spur Progress Toward Parkinson's Cure

May 31, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 31, 2011 /PRNewswire-USNewswire/ --Sergey Brin and Anne Wojcicki announced a $50-million challenge spurring existing and new donors at every level to give, or increase giving, to The Michael J. Fox Foundation for Parkinson's Research (MJFF). The Challenge is now in effect...

Caliper Life Sciences to Present at Jefferies 2011 Global Healthcare Conference

May 31, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

HOPKINTON, Mass., May 31, 2011 /- Caliper Life Sciences, Inc. (NASDAQ: CALP ) today announced that its presentation at the Jefferies 2011 Global Life Sciences Conference, will be webcast on Wednesday, June 8 at 11:00 a.m. EDT.  Kevin Hrusovsky, President and CEO of Caliper, will be...

Genetic Technologies Processes First BREVAGenâ„¢ Patient Sample

May 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

VICTORIA, Australia, May 31, 2011 /- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE ) has received and processed its first BREVAGen ™ clinical sample from a US patient.  This follows last month's receipt of certification of its Australian laboratory under the US Clinical...

West to Present at Jefferies Conference

May 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

LIONVILLE, Pa., May 31, 2011 /- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that management will attend the Jefferies 2011 Global Healthcare Conference in New York, NY.  Management will present an overview of West's business and outlook on Monday, June 6, 2011 at...

Abaxis to Present at Jefferies' 2011 Global Healthcare Conference

May 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., May 31, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Don Wood, chief operations officer,  will present at Jefferies' 2011 Global Healthcare Conference on Tuesday, June 7,...

MultiCell Technologies is Granted Stem Cell Patent

May 31, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., May 31, 2011 /- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET ) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent and Trademark Office (USPTO) relating to the isolation and use of human liver stem cells to treat liver...

HistoRx finds $2.6M funding for personalized cancer care

May 31, 2011 5:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

HistoRx Inc., a tissue-based diagnostics firm in Branford, Conn., has raised $2.6 million in a financing filed with the U.S. Securities and Exchange Commission. The company focuses on developing personalized cancer treatments based on its automated quantitative analysis technology, which...

Cloud Computing Creates Climate Change in Teleradiology

May 31, 2011 5:32 am | by Diagnostic Imaging | News | Comments

How teleradiology is leveraging the cloud computing trend -- and doing it differently than non-healthcare companies

MRI Can Detect Pre-Clinical Alzheimer's Disease, Says New Study

May 31, 2011 5:32 am | by Diagnostic Imaging | News | Comments

Participants underwent an MRI exam at the beginning of the study, and again two years later. Researchers also then tested the participants' memory using several scales. From the memory tests, researchers identified 25 participants (17 percent) whose memory declined during the two years,...

PositiveID Corporation Receives NASDAQ Extension to Regain Compliance With Minimum Bid Price -- 180 Days From Notice Date

May 31, 2011 5:32 am | by PositiveID | News | Comments

PositiveID Corporation Receives NASDAQ Extension to Regain Compliance With Minimum Bid Price -- 180 Days From Notice Date

Endo Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 31, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., May 31, 2011 /- Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that Julie McHugh, chief operating officer and Alan Levin, executive vice president and chief financial officer will present a corporate overview at the Jefferies Global Healthcare Conference on...

United Kingdom's National Institute for Health and Clinical Excellence Issues Guidance on Percutaneous Tibial Nerve Stimulation for Faecal Incontinence

May 31, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, May 31, 2011 /- Uroplasty, Inc. (NASDAQ: UPI ), announced today that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) issued guidance on percutaneous tibial nerve stimulation (PTNS) for the treatment of faecal incontinence.  In October...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading